Latest from Novocure and GT Medical Technologies
Novocure and GT Medical Technologies continue to move forward and make progress in their research to creating a better quality of life for patients and improving survival rates.
July 22, 2020
Novocure and GT Medical Technologies continue to move forward and make progress in their research to creating a better quality of life for patients and improving survival rates.
July 22, 2020
Initiated by the nonprofit, OurBrainBank, Brains for the Cure and many other advocacy groups, including Head for the Cure, are honored to present the Glioblastoma Bill of Rights. It is estimated that 87,000 people will …
July 22, 2020
Written by: Courtney Benisch – Regional Relationship Coordinator for Head for the Cure This year has been nothing but a roller coaster, and as a caregiver, I cannot even imagine what it is like watching …
July 16, 2020
Brains for the Cure (BFTC) is thrilled to announce a new partnership with the creators of GammaTile®, GT Medical Technologies, to provide resources and guidance for caregivers of brain tumor patients.
July 9, 2020
It had been two months since I started a new course of chemotherapy, and I tried to imagine the damage it dealt to the tumor in my head.
June 30, 2020
Learn about a a variety of topics surrounding telehealth options for brain tumor patients.
June 24, 2020
The next post in Jenguin’s Journey covers how Jenny has had to adjust her diet during treatment.
June 15, 2020
Brains for the Cure joins NCI-Connect as a Rare Brain and Spine Tumor Support Organizations to support their efforts to support patients and caregivers facing a brain tumor diagnosis.
June 5, 2020
Written by Jenny Williams (aka ‘Jenguin’) – Head for the Cure Ambassador Watching TV, you’re bound to see one of those commercials for a pharmaceutical drug where they list out the side effects, and somewhere …
May 29, 2020
In some cases, patients with brain tumors and other serious conditions can get permission to try treatments that haven’t yet gone through this process, thanks to the FDA’s Expanded Access program.
May 28, 2020